Provided by Tiger Trade Technology Pte. Ltd.

Duan Yongping

5,325.43
+116.052.23%
Number of Gainers:4
Number of Losers:3
Number of Flat:- -
PE:- -
High:5,353.36
Open:5,210.03
Low:5,176.44
Close:5,208.16
Volume:78.73M
Turnover:17.79B
Market Cap:5.65T
Float Cap:5.54T

Loading ...

BofA Securities Upgrades Moderna to Neutral From Underperform Following Intismeran 'Success', Raises Price Target to $170 From $40

MT Newswires Live
·
Aug 20

Asia Morning Call-Global Markets

Reuters
·
Aug 20

Top Midday Gainers

MT Newswires Live
·
Aug 20

U.S. Stocks on the MOVE-ServiceNow, Zoom, US Homebuilders

Reuters
·
Aug 20

Moderna upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Aug 20

Short Sellers Lose $4.8 Billion as Moderna Stock (MRNA) Soars 150%

TIPRANKS
·
Aug 20

Apple and UMG Announce E-Commerce and Merchandise Partnership for the Beatles

Reuters
·
Aug 20

US Equity Indexes Rise as Treasury Yields Ease on Buyback Ramp

MT Newswires Live
·
Aug 20

Moderna $30 Bln Gain Implies Many Cancer Successes

Reuters
·
Aug 20

Moderna Stock (MRNA) Soars 133%; Five-Star William Blair Analyst Says Strong Cancer Data Could Be a Game-Changer

TIPRANKS
·
Aug 20

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Aug 20

Flash Heard: Why Healthcare is Partying Like It's Late 2020

Dow Jones
·
Aug 20

Why Apple Stock Is Rising Today and What Wall Street Sees Ahead – August 19

TIPRANKS
·
Aug 19

Goldman Sachs Adjusts Price Target on Moderna to $120 From $67, Keeps Neutral Rating

MT Newswires Live
·
Aug 19

Why 2026 is Biotech's Comeback Year

Dow Jones
·
Aug 19

Moderna data bode well for Sellas into imminent readout, says Maxim

TIPRANKS
·
Aug 19

General Electric Co Stock (GE) Moved Down by 3.30% on Aug 19: Facts Behind the Movement

TradingKey
·
Aug 19

Moderna : RBC Raises Target Price to $130 from $45

THOMSON REUTERS
·
Aug 19

Apple Stock Forecast: Reclaims $315 After Two-Day Rise, Diverges From SOX Again — Can the Rebound Continue?

TradingKey
·
Aug 19

Leerink says cancer vaccine win should sustain Merck momentum into fall

TIPRANKS
·
Aug 19